Enteritis with immune checkpoint inhibitor use

CMAJ. 2019 Oct 7;191(40):E1106. doi: 10.1503/cmaj.190244.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / adverse effects*
  • Colonoscopy
  • Endoscopy, Digestive System
  • Enteritis / chemically induced*
  • Humans
  • Ipilimumab / adverse effects*
  • Male
  • Melanoma / drug therapy*
  • Nivolumab / adverse effects*

Substances

  • Antineoplastic Agents, Immunological
  • Ipilimumab
  • Nivolumab